North America’s BEST Small Cap Stock Ideas
At a time of year when the number of press releases is relatively low, one Company, that we have been following for some time, stood out this week with two announcements: Clearfield Inc. (CLFD – $1.77) . Clearfield, which manufactures and sells fiber distribution systems, optical components, outside plant cabinets, and fiber and copper cable assemblies for the telecommunications industry, […]
Read more
With the second quarter a few days behind us, it’s time to find out how some of the companies that we track performed. With us to discuss the second quarter and many more interesting items that happened since our previous interview is Mr. Walter Johnsen, Exec. Chairman and CEO of Acme United Corp. (ACU – $9.00). Click the start button […]
Read moreNext to Hemispherx Biopharma Inc. (+ 572% since our recommendation) and Orsus Xelent Inc (+ 65% since our recommendation), we have a few more aces up our sleeve. Take, for instance, Global Green Solutions Inc. (GGRN – $0.12) , which we first recommended at $0.06 a few months ago, is making progress in both its business units: Greensteam, a commercial […]
Read moreOur guest today is Mr. Karl Puehringer, President and CEO of Baldwin Technology Co. Inc. (BLD – $0.91). Baldwin Technology Company, Inc., together with its subsidiaries, engages primarily in the development, manufacture, and sale of process automation equipment for the printing and publishing industry. Mr. Puehringer discusses the Company and the markets it operates in. Click the start button underneath […]
Read moreA few weeks ago, we wrote Hemispherx Biopharma’s (HEB – $2.73) shares were on a rollercoaster and it seems the ride is getting wilder and wilder. Obviously, there’s a tremendous amount of speculation about the FDA’s decision to approve Ampligen for Chronic Fatigue Syndrome (CFS). Based on all the public information out there, you have to form an opinion, and […]
Read moreWe recommended Orsus Xelent Technologies Inc. (ORS – $0.91) on January 10, 2009, at $0.47 as one of our three stocks for 2009. Although there was no real catalyst, the stock went up almost 50% this week. The Company did report strong first quarter results on May 20th and this week’s jump may be a late reaction to it. We […]
Read moreFor many this is starting to look like a soap opera, but contrary to the TV version, this is extremely exciting. Obviously, we’re talking about Hemispherx Biopharma (HEB) and the big question will the FDA give its thumbs up to bring Ampligen to the market. The introduction to the next episode was given on Tuesday morning when HEB issued a […]
Read moreOrsus Xelent Technologies, Inc. (ORS) our designer and manufacturer of mobile phones for the Asian market, announced that its first quarter revenues declined about 4.8% compared with the same period last year to $19.7 million. However, the Company’s net income rose 11.4% to $2.2 million or 7 cents per share. In these market circumstances, that’s a great performance! These numbers […]
Read moreMost Hemispherx Biopharma (HEB) shareholders must be feeling sick after being on a rollercoaster ride an entire week. The stock went up and down and traded more than 90 million shares only to finish 1 cent below where it closed last Friday. Two months ago, barely 200,000 shares changed hands in a week’s time. On Tuesday, the Company announced a […]
Read moreIn this update report (pdf) we discuss Acme United’s (ACU – $7.42) first quarter results. We explain why we feel this stock is undervalued at current levels and we give an outlook for the near term future. Underneath are a few highlights from the report: Even in these difficult market circumstances, the Company was able to gain 5 large mass […]
Read more